1. AB0376 Neither RA Disease Activity nor TNFI Increase the Incidence of Lymphoma in A Large, US RA Registry. (10th June 2014) Authors: Furst, D.E.; Cox, V.; Etzel, C.J.; Greenberg, J.D.; Collier, D. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 930 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0378 Anti-Drug Antibody (ADAB) Differentially Affect Response among Specific TNFI and Also among Diseases: an SLR and Meta-Analysis. (10th June 2014) Authors: Borazan, N.; Thomas, S.; Barroso, N.; Duan, L.; Furst, D.E. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 930 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0455 Disease duration, but not rheumatoid factor status, impacts clinical response in adalimumab-treated rheumatoid arthritis patients with an inadequate response to standard dmard therapy: Subgroup analysis of the DE020 continuation trial. (23rd January 2014) Authors: Furst, D.E.; Weinblatt, M.E.; Kavanaugh, A.; Birbara, C.; Kupper, H.; Obermeyer, K.; Faccin, F. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0456 Improvement and maintenance of hemoglobin levels among rheumatoid arthritis, psoriatic arthritis & ankylosing spondylitis patients with anemia of inflammation after treatment with golimumab: 3 yr pooled analysis from golimumab rheumatology clinical program. (23rd January 2014) Authors: Furst, D.E.; Gathany, T.A.; Kay, J.; Wasko, M.C.; Keystone, E.; Kavanaugh, A.; Deodhar, A.; Murphy, F.; Han, C.; Doyle, M.K. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0479 Patient outcomes following 10 years of treatment with adalimumab in the DE020 roll-over trial. (23rd January 2014) Authors: Weinblatt, M.E.; Furst, D.E.; Kavanaugh, A.; Faccin, F.; Kupper, H.; Obermeyer, K.; Birbara, C. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0480 Certolizumab pegol plus methotrexate is similarly effective in active rheumatoid arthritis regardless of prior TNF inhibitor use: Analysis of the doseflex PHASE IIIB study. (23rd January 2014) Authors: Schiff, M.; Davies, O.; Bennett, B.; Luijtens, K.; Furst, D.E. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0156 Adalimumab treatment is associated with decreased concomitant RA medication use over 24 months. (23rd January 2014) Authors: Furst, D.E.; Mozaffarian, N.; Grant, S.; Cifaldi, M.; Clewell, J.; Kremer, J.; Shaw, J.W. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OP0002 Use of anti-TNF therapy is associated with reduced cardiovascular event risk in rheumatoid arthritis. (23rd January 2014) Authors: Nurmohamed, M.T.; Bao, Y.; Signorovitch, J.; Mulani, P.M.; Furst, D.E. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OP0026 Induction of Clinical Remission Followed by Drug-Free Withdrawal with Abatacept Combination and Monotherapy in Early RA: Results from the AVERT Study over 18 Months. (10th June 2014) Authors: Emery, P.; Burmester, G.; Bykerk, V.; Combe, B.; Furst, D.E.; Barre, E.; Karyekar, C.S.; Wong, D.; Huizinga, T.W. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP0030 Mri Results from the AVERT Study: A Randomized, Active-Controlled TRIAL to Evaluate Induction of Remission and Maintenance of Drug-Free Remission Using Abatacept in Combination with Methotrexate or as Monotherapy in Patients with Early RA. (10th June 2014) Authors: Peterfy, C.; Burmester, G.; Bykerk, V.; Combe, B.; Furst, D.E.; Huizinga, T.W.; Karyekar, C.S.; Wong, D.; Conaghan, P.; Emery, P. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗